When Marty Makary officially became Food and Drug Administration commissioner Tuesday night, he inherited the explosive matter of mifepristone access — an issue that hung over and complicated his confirmation process.

The U.S. Senate confirmed Marty Makary as commissioner of the Food and Drug Administration mostly along party lines on Tuesday night.

Both agencies are part of the Department of Health and Human Services, which like much of the federal government, has seen mass layoffs as part of the Trump administration's ongoing efforts to implement budget cuts.